Pancreatic Cancer Research

ResearcherUniversity of SurreyActive in the last 2 years

Simon de Lusignan

Matched on ORCID iD 0000-0002-8553-2641; OpenAlex author ID A5006687609, A5146808398. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. Comparing Weight Loss Prior to Pancreatic Cancer Diagnosis in Cases and Controls: A Systematic Review and Meta-Analysis. Co-author DOI 10.3233/shti260172↗
  2. Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC): external validation using English sentinel network. Co-author DOI 10.3399/bjgp.2024.0253↗
  3. Sociodemographic Profile of People with Diagnosed Pancreatic Cancer in the UK: Retrospective Sentinel Network Cohort Study. Co-author DOI 10.3233/shti250563↗
  4. External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocol Co-author DOI 10.1101/2024.05.21.24307690↗
  5. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol. Co-author DOI 10.1136/bmjopen-2023-079863↗
  6. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database. Last author DOI 10.1371/journal.pone.0275369↗
  7. Using Primary Care Data to Report Real-World Pancreatic Cancer Survival and Symptomatology. Last author DOI 10.3233/shti210142↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Agnieszka Lemańska · 7 shared papers, 2021–2026 · strength 1.65
  2. Claire A. Price · 6 shared papers, 2022–2026 · strength 1.53
  3. Hugh Claridge · 3 shared papers, 2024–2026 · strength 0.73
  4. Natalia I. Khalaf · 3 shared papers, 2024–2026 · strength 0.73
  5. Nathan Jeffreys · 2 shared papers, 2021–2022 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.